Advertisement
Canada markets open in 3 hours 28 minutes

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7309
    -0.0011 (-0.15%)
     

  • CRUDE OIL

    82.97
    -0.39 (-0.47%)
     

  • Bitcoin CAD

    90,745.70
    +262.67 (+0.29%)
     

  • CMC Crypto 200

    1,431.62
    +7.52 (+0.53%)
     

  • GOLD FUTURES

    2,328.70
    -13.40 (-0.57%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,671.50
    +64.75 (+0.37%)
     

  • VOLATILITY

    15.87
    +0.18 (+1.15%)
     

  • FTSE

    8,083.87
    +39.06 (+0.49%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6838
    +0.0002 (+0.03%)
     

Company News for Dec 4, 2019

Zacks Equity Research

  • UnitedHealth Group Inc.’s UNH shares fell 1% after the company declared that its full year 2020 adjusted earnings per share will be in the range of $16.25-$16.55. Its mid-point of $16.40 lagged the current Zacks Consensus Estimate of $16.44.

  • PepsiCo Inc. PEP dropped 0.3% after the company decided to acquire BFY Brands Inc. for an undisclosed sum.

  • Shares of Cleveland-Cliffs Inc. CLF plunged 10.7% following its decision to acquire AK Steel Holding Corp. AKS for a consideration of $1.1 billion in an all-stock deal.

  • Audentes Therapeutics Inc. BOLD jumped 106% following news that Japan’s Astellas Pharma Inc. will acquire the company for a consideration of $3 billion in cash.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PepsiCo, Inc. (PEP) : Free Stock Analysis Report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Cleveland-Cliffs Inc. (CLF) : Free Stock Analysis Report
 
AK Steel Holding Corporation (AKS) : Free Stock Analysis Report
 
Audentes Therapeutics, Inc. (BOLD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research